4:03 PM ET
10-Q
Financial Results
BioKey Q3 2026 Results: Net Loss of $398K, Loss Widens
BioKey (Cayman), Inc. reported zero revenue for the nine months ended September 30, 2026, with a net loss of $873,721 compared to $538,188 in the prior year period. The company remains heavily dependent on recurring loans from ABVC BioPharma, Inc. to support its operations, with total liabilities reaching $7.56 million against total assets of $1.61 million.
- Key figure
- Net loss $398K